Skip to main content
Top
Published in: BMC Psychiatry 1/2024

Open Access 01-12-2024 | Smoking and Nicotine Detoxification | Study Protocol

A randomized controlled trial of potential tobacco policies prohibiting menthol flavor in cigarettes and e-cigarettes: a study protocol

Authors: Krysten W. Bold, Akshika Sharma, Angela Haeny, Ralitza Gueorguieva, Eugenia Buta, Stephen Baldassarri, Lauren Lempert, Suchitra Krishnan-Sarin, Stephanie O’Malley

Published in: BMC Psychiatry | Issue 1/2024

Login to get access

Abstract

Background

Menthol cigarette use remains a large public health problem and disproportionately affects Black adults in the United States. The Food and Drug Administration has proposed prohibiting menthol flavor in cigarettes to protect public health. However, e-cigarettes are available in menthol flavor and are a popular alternative product adults might switch to if menthol is prohibited in cigarettes. Research is needed to understand how availability of menthol (vs. tobacco) flavored e-cigarettes could impact cigarette use among adults who smoke menthol cigarettes.

Methods

We will recruit 150 adults who currently smoke menthol cigarettes and will randomize them to 1 of 3 conditions modeling different regulatory scenarios. We will recruit equal numbers of participants identifying as Black vs. non-Black and will stratify randomization by race. To promote standardization and adherence, cigarette and e-cigarette products will be provided for 8 weeks based on the assigned condition: (A) no menthol restriction (menthol cigarette and menthol flavored e-cigarette), (B) menthol prohibited in cigarettes only (non-menthol cigarette and menthol flavored e-cigarette), (C) menthol prohibited in both cigarettes and e-cigarettes (non-menthol cigarette and tobacco flavored e-cigarette). A follow-up visit will occur at week 12 to assess tobacco use status. The study aims are to (1) examine the impact of prohibiting menthol flavor in cigarettes and e-cigarettes on smoking behavior and (2) investigate whether outcomes differ by race to understand the impact of menthol policies on Black (vs. non-Black) individuals given high rates of menthol cigarette use in this population. The primary outcome will evaluate changes in the number of cigarettes smoked per day during the 8-week study period and will examine differences by regulatory scenario. Secondary outcomes will compare percent days smoke-free, changes in nicotine dependence, and motivation, confidence, and intentions to quit smoking by the regulatory scenarios. We will examine whether changes in the outcomes differ by Black vs. non-Black participants to compare the magnitude of the effect of the various menthol policy scenarios by race.

Discussion

Results will contribute critical information regarding menthol in cigarettes and e-cigarettes to inform regulatory policies that maximize reductions in cigarette smoking and reduce tobacco-related health disparities.

Trial registration

NCT05259566. Yale IRB protocol #2000032211, last approved 12/8/2023.
Literature
1.
go back to reference USDHHS. The health consequences of smoking—50 years of progress: a report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services. Volume 17. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. USDHHS. The health consequences of smoking—50 years of progress: a report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services. Volume 17. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
2.
go back to reference World Health Organization. WHO global report: Mortality attributable to tobacco. 2012. World Health Organization. WHO global report: Mortality attributable to tobacco. 2012.
3.
go back to reference The NSDUH, Report. Recent Trends in Menthol Cigarette Use [press release]. November 18, 2011 2011. The NSDUH, Report. Recent Trends in Menthol Cigarette Use [press release]. November 18, 2011 2011.
4.
go back to reference Villanti AC, Mowery PD, Delnevo CD, Niaura RS, Abrams DB, Giovino GA. Changes in the prevalence and correlates of menthol cigarette use in the USA, 2004–2014. Tob Control. 2016;25(Suppl 2):ii14–ii20.PubMedCrossRef Villanti AC, Mowery PD, Delnevo CD, Niaura RS, Abrams DB, Giovino GA. Changes in the prevalence and correlates of menthol cigarette use in the USA, 2004–2014. Tob Control. 2016;25(Suppl 2):ii14–ii20.PubMedCrossRef
6.
go back to reference Levy DT, Blackman K, Tauras J, Chaloupka FJ, Villanti AC, Niaura RS, et al. Quit attempts and quit rates among menthol and nonmenthol smokers in the United States. Am J Public Health. 2011;101(7):1241–7.PubMedPubMedCentralCrossRef Levy DT, Blackman K, Tauras J, Chaloupka FJ, Villanti AC, Niaura RS, et al. Quit attempts and quit rates among menthol and nonmenthol smokers in the United States. Am J Public Health. 2011;101(7):1241–7.PubMedPubMedCentralCrossRef
7.
go back to reference Ho JY, Elo IT. The contribution of smoking to black-white differences in US mortality. Demography. 2013;50(2):545–68.PubMedCrossRef Ho JY, Elo IT. The contribution of smoking to black-white differences in US mortality. Demography. 2013;50(2):545–68.PubMedCrossRef
8.
go back to reference World Health Organization Study Group on Tobacco Product Regulation. Advisory note: banning Menthol in Tobacco products. Geneva, Switzerland: World Health Organization; 2016. World Health Organization Study Group on Tobacco Product Regulation. Advisory note: banning Menthol in Tobacco products. Geneva, Switzerland: World Health Organization; 2016.
9.
go back to reference Kyriakos CN, Driezen P, Fong G, Chung-Hall J, Hyland A, Geboers C et al. Impact of the European Union’s menthol cigarette ban on smoking cessation outcomes: longitudinal findings from the 2020–2021 ITC Netherlands surveys. Tob Control. 2022. Kyriakos CN, Driezen P, Fong G, Chung-Hall J, Hyland A, Geboers C et al. Impact of the European Union’s menthol cigarette ban on smoking cessation outcomes: longitudinal findings from the 2020–2021 ITC Netherlands surveys. Tob Control. 2022.
10.
go back to reference Chung-Hall J, Fong GT, Meng G, Cummings KM, Hyland A, O’Connor RJ, et al. Evaluating the impact of menthol cigarette bans on cessation and smoking behaviours in Canada: longitudinal findings from the Canadian arm of the 2016–2018 ITC Four Country smoking and vaping surveys. Tob Control. 2022;31(4):556–63.PubMedCrossRef Chung-Hall J, Fong GT, Meng G, Cummings KM, Hyland A, O’Connor RJ, et al. Evaluating the impact of menthol cigarette bans on cessation and smoking behaviours in Canada: longitudinal findings from the Canadian arm of the 2016–2018 ITC Four Country smoking and vaping surveys. Tob Control. 2022;31(4):556–63.PubMedCrossRef
11.
go back to reference Tobacco. product standard for menthol in cigarettes, 87 FR 26454 (2022). Tobacco. product standard for menthol in cigarettes, 87 FR 26454 (2022).
12.
go back to reference Tobacco Products Scientific Advisory Committee. Menthol cigarettes and public health: review of the scientific evidence and recommendations. Washington DC: US Food and Drug Administration; 2011. Tobacco Products Scientific Advisory Committee. Menthol cigarettes and public health: review of the scientific evidence and recommendations. Washington DC: US Food and Drug Administration; 2011.
13.
go back to reference FDA. Preliminary scientific evaluation of the possible public health effects of menthol versus nonmenthol cigarettes. Silver Spring, MD: Center for Tobacco Products, Food and Drug Administration; 2013. FDA. Preliminary scientific evaluation of the possible public health effects of menthol versus nonmenthol cigarettes. Silver Spring, MD: Center for Tobacco Products, Food and Drug Administration; 2013.
14.
go back to reference O’Connor RJ, Bansal-Travers M, Carter LP, Cummings KM. What would menthol smokers do if menthol in cigarettes were banned? Behavioral intentions and simulated demand. Addiction. 2012;107(7):1330–8.PubMedPubMedCentralCrossRef O’Connor RJ, Bansal-Travers M, Carter LP, Cummings KM. What would menthol smokers do if menthol in cigarettes were banned? Behavioral intentions and simulated demand. Addiction. 2012;107(7):1330–8.PubMedPubMedCentralCrossRef
15.
go back to reference Chaiton M, Schwartz R, Cohen JE, Soule E, Eissenberg T. Association of Ontario’s ban on menthol cigarettes with smoking behavior 1 month after implementation. JAMA Intern Med. 2018;178(5):710–1.PubMedPubMedCentralCrossRef Chaiton M, Schwartz R, Cohen JE, Soule E, Eissenberg T. Association of Ontario’s ban on menthol cigarettes with smoking behavior 1 month after implementation. JAMA Intern Med. 2018;178(5):710–1.PubMedPubMedCentralCrossRef
16.
go back to reference Levy DT, Pearson JL, Villanti AC, Blackman K, Vallone DM, Niaura RS, et al. Modeling the future effects of a menthol ban on smoking prevalence and smoking-attributable deaths in the United States. Am J Public Health. 2011;101(7):1236–40.PubMedPubMedCentralCrossRef Levy DT, Pearson JL, Villanti AC, Blackman K, Vallone DM, Niaura RS, et al. Modeling the future effects of a menthol ban on smoking prevalence and smoking-attributable deaths in the United States. Am J Public Health. 2011;101(7):1236–40.PubMedPubMedCentralCrossRef
17.
go back to reference Chaiton MO, Nicolau I, Schwartz R, Cohen JE, Soule E, Zhang B et al. Ban on menthol-flavoured tobacco products predicts cigarette cessation at 1 year: a population cohort study. Tob Control. 2019:tobaccocontrol–2018. Chaiton MO, Nicolau I, Schwartz R, Cohen JE, Soule E, Zhang B et al. Ban on menthol-flavoured tobacco products predicts cigarette cessation at 1 year: a population cohort study. Tob Control. 2019:tobaccocontrol–2018.
18.
go back to reference Cadham CJ, Sanchez-Romero LM, Fleischer NL, Mistry R, Hirschtick JL, Meza R, et al. The actual and anticipated effects of a menthol cigarette ban: a scoping review. BMC Public Health. 2020;20(1):1–17.CrossRef Cadham CJ, Sanchez-Romero LM, Fleischer NL, Mistry R, Hirschtick JL, Meza R, et al. The actual and anticipated effects of a menthol cigarette ban: a scoping review. BMC Public Health. 2020;20(1):1–17.CrossRef
19.
go back to reference Bold KW, Jatlow P, Fucito LM, Eid T, Krishnan-Sarin S, O’Malley S. Evaluating the effect of switching to non-menthol cigarettes among current menthol smokers: an empirical study of a potential ban of characterising menthol flavour in cigarettes. Tob Control. 2020;29:624–30.PubMed Bold KW, Jatlow P, Fucito LM, Eid T, Krishnan-Sarin S, O’Malley S. Evaluating the effect of switching to non-menthol cigarettes among current menthol smokers: an empirical study of a potential ban of characterising menthol flavour in cigarettes. Tob Control. 2020;29:624–30.PubMed
20.
go back to reference Tobacco product standard for characterizing flavors in cigars, 87 FR 26396. (2022). Tobacco product standard for characterizing flavors in cigars, 87 FR 26396. (2022).
21.
go back to reference FDA. Deeming Tobacco Products To Be Subject to the Federal Food. Drug, and Cosmetic Act, as amended by the Family Smoking Prevention and Tobacco Control Act; restrictions on the sale and distribution of Tobacco products and Required Warning Statements for Tobacco Products. Final rule. Fed Regist. 2016;81(90):28973. FDA. Deeming Tobacco Products To Be Subject to the Federal Food. Drug, and Cosmetic Act, as amended by the Family Smoking Prevention and Tobacco Control Act; restrictions on the sale and distribution of Tobacco products and Required Warning Statements for Tobacco Products. Final rule. Fed Regist. 2016;81(90):28973.
22.
go back to reference FDA finalizes enforcement policy on unauthorized flavored cartridge-based. e-cigarettes that appeal to children, including fruit and mint [press release]. 2020. FDA finalizes enforcement policy on unauthorized flavored cartridge-based. e-cigarettes that appeal to children, including fruit and mint [press release]. 2020.
23.
go back to reference Administration FaD. Enforcement priorities for Electronic Nicotine Delivery Systems (ENDS) and Other Deemed Products on the Market Without Premarket Authorization (Revised). 2020. Report No.: FDA-2019-D-0661. Administration FaD. Enforcement priorities for Electronic Nicotine Delivery Systems (ENDS) and Other Deemed Products on the Market Without Premarket Authorization (Revised). 2020. Report No.: FDA-2019-D-0661.
24.
go back to reference Hung F, Wallach JD, O’Malley SS, Bold KW. Characteristics of registered clinical trials evaluating the role of e-Cigarettes in Cessation or reduction of cigarette smoking. JAMA Psych. 2021;78(11):1280–3.CrossRef Hung F, Wallach JD, O’Malley SS, Bold KW. Characteristics of registered clinical trials evaluating the role of e-Cigarettes in Cessation or reduction of cigarette smoking. JAMA Psych. 2021;78(11):1280–3.CrossRef
25.
go back to reference Cornelius ME, Loretan CG, Jamal A, Lynn BCD, Mayer M, Alcantara IC, et al. Tobacco product use among adults–United States, 2021. Morb Mortal Wkly Rep. 2023;72(18):475.CrossRef Cornelius ME, Loretan CG, Jamal A, Lynn BCD, Mayer M, Alcantara IC, et al. Tobacco product use among adults–United States, 2021. Morb Mortal Wkly Rep. 2023;72(18):475.CrossRef
26.
go back to reference Gades MS, Alcheva A, Riegelman AL, Hatsukami DK. The role of nicotine and flavor in the abuse potential and appeal of electronic cigarettes for adult current and former cigarette and electronic cigarette users: a systematic review. Nicotine Tob Res. 2022:1–12. Gades MS, Alcheva A, Riegelman AL, Hatsukami DK. The role of nicotine and flavor in the abuse potential and appeal of electronic cigarettes for adult current and former cigarette and electronic cigarette users: a systematic review. Nicotine Tob Res. 2022:1–12.
27.
go back to reference Hajek P, Pittaccio K, Pesola F, Myers Smith K, Phillips-Waller A, Przulj D. Nicotine delivery and users’ reactions to Juul compared with cigarettes and other e‐cigarette products. Addiction. 2020;115(6):1141–8.PubMedPubMedCentralCrossRef Hajek P, Pittaccio K, Pesola F, Myers Smith K, Phillips-Waller A, Przulj D. Nicotine delivery and users’ reactions to Juul compared with cigarettes and other e‐cigarette products. Addiction. 2020;115(6):1141–8.PubMedPubMedCentralCrossRef
28.
go back to reference Goniewicz ML, Gawron M, Smith DM, Peng M, Jacob P, Benowitz NL. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study. Nicotine Tob Res. 2017;19(2):160–7.PubMedCrossRef Goniewicz ML, Gawron M, Smith DM, Peng M, Jacob P, Benowitz NL. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study. Nicotine Tob Res. 2017;19(2):160–7.PubMedCrossRef
29.
go back to reference Lindson N, Butler AR, McRobbie H, Bullen C, Hajek P, Begh R et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2024(1). Lindson N, Butler AR, McRobbie H, Bullen C, Hajek P, Begh R et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2024(1).
30.
go back to reference Bold KW, Buta E, Simon P, Gueorguieva R, Jackson A, Suttiratana SC et al. Examining the potential role of e-cigarettes to reduce health disparities associated with menthol cigarette use: characterizing e-cigarette use, flavors, and reasons for use among US adults smoking menthol cigarettes. Drug Alcohol Depend. 2022:109475. Bold KW, Buta E, Simon P, Gueorguieva R, Jackson A, Suttiratana SC et al. Examining the potential role of e-cigarettes to reduce health disparities associated with menthol cigarette use: characterizing e-cigarette use, flavors, and reasons for use among US adults smoking menthol cigarettes. Drug Alcohol Depend. 2022:109475.
31.
go back to reference Hooper MW, Smiley SL. Comparison of e-cigarette use among menthol and non-menthol smokers: findings from a community based sample. Ethn Dis. 2018;28(3):153.CrossRef Hooper MW, Smiley SL. Comparison of e-cigarette use among menthol and non-menthol smokers: findings from a community based sample. Ethn Dis. 2018;28(3):153.CrossRef
32.
go back to reference Kotlyar M, Shanley R, Dufresne SR, Corcoran GA, Hatsukami DK. Effect on Tobacco Use and subjective measures of including E-cigarettes in a simulated Ban of Menthol in Combustible cigarettes. Nicotine Tob Res. 2022;24(9):1448–57.PubMedPubMedCentralCrossRef Kotlyar M, Shanley R, Dufresne SR, Corcoran GA, Hatsukami DK. Effect on Tobacco Use and subjective measures of including E-cigarettes in a simulated Ban of Menthol in Combustible cigarettes. Nicotine Tob Res. 2022;24(9):1448–57.PubMedPubMedCentralCrossRef
33.
go back to reference Hatsukami DK, Meier E, Lindgren BR, Anderson A, Reisinger SA, Norton KJ, et al. A randomized clinical trial examining the effects of instructions for electronic cigarette use on smoking-related behaviors and biomarkers of exposure. Nicotine Tob Res. 2020;22(9):1524–32.PubMedCrossRef Hatsukami DK, Meier E, Lindgren BR, Anderson A, Reisinger SA, Norton KJ, et al. A randomized clinical trial examining the effects of instructions for electronic cigarette use on smoking-related behaviors and biomarkers of exposure. Nicotine Tob Res. 2020;22(9):1524–32.PubMedCrossRef
34.
go back to reference Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, et al. Randomized trial of reduced-nicotine standards for cigarettes. N Engl J Med. 2015;373(14):1340–9.PubMedPubMedCentralCrossRef Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, et al. Randomized trial of reduced-nicotine standards for cigarettes. N Engl J Med. 2015;373(14):1340–9.PubMedPubMedCentralCrossRef
35.
go back to reference Hatsukami DK, Kotlyar M, Hertsgaard LA, Zhang Y, Carmella SG, Jensen JA, et al. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction. 2010;105(2):343–55.PubMedPubMedCentralCrossRef Hatsukami DK, Kotlyar M, Hertsgaard LA, Zhang Y, Carmella SG, Jensen JA, et al. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction. 2010;105(2):343–55.PubMedPubMedCentralCrossRef
36.
go back to reference Mercincavage M, Souprountchouk V, Tang KZ, Dumont RL, Wileyto EP, Carmella SG et al. A randomized controlled trial of progressively reduced nicotine content cigarettes on smoking behaviors, biomarkers of exposure, and subjective ratings. Cancer Epidemiol Biomarkers Prev. 2016:cebp. 1088.2015. Mercincavage M, Souprountchouk V, Tang KZ, Dumont RL, Wileyto EP, Carmella SG et al. A randomized controlled trial of progressively reduced nicotine content cigarettes on smoking behaviors, biomarkers of exposure, and subjective ratings. Cancer Epidemiol Biomarkers Prev. 2016:cebp. 1088.2015.
37.
go back to reference Huang J, Duan Z, Kwok J, Binns S, Vera LE, Kim Y, et al. Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market. Tob Control. 2019;28:146–51.PubMedCrossRef Huang J, Duan Z, Kwok J, Binns S, Vera LE, Kim Y, et al. Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market. Tob Control. 2019;28:146–51.PubMedCrossRef
38.
go back to reference Conway J. Vaping market share in the United States in 2020, by brand. 2020. Conway J. Vaping market share in the United States in 2020, by brand. 2020.
39.
go back to reference Nardone N, Helen GS, Addo N, Meighan S, Benowitz NL. JUUL electronic cigarettes: Nicotine exposure and the user experience. Drug Alcohol Depend. 2019;203:83–7.PubMedPubMedCentralCrossRef Nardone N, Helen GS, Addo N, Meighan S, Benowitz NL. JUUL electronic cigarettes: Nicotine exposure and the user experience. Drug Alcohol Depend. 2019;203:83–7.PubMedPubMedCentralCrossRef
40.
go back to reference Brown J, DeAtley T, Welding K, Schwartz R, Chaiton M, Lawrence Kittner D, et al. Tobacco industry response to menthol cigarette bans in Alberta and Nova Scotia, Canada. Tob Control. 2017;26(e1):e71–e4.PubMedCrossRef Brown J, DeAtley T, Welding K, Schwartz R, Chaiton M, Lawrence Kittner D, et al. Tobacco industry response to menthol cigarette bans in Alberta and Nova Scotia, Canada. Tob Control. 2017;26(e1):e71–e4.PubMedCrossRef
41.
go back to reference Schwartz R, Chaiton M, Borland T, Diemert L. Tobacco industry tactics in preparing for menthol ban. Tob Control. 2018;27(5):577.PubMedCrossRef Schwartz R, Chaiton M, Borland T, Diemert L. Tobacco industry tactics in preparing for menthol ban. Tob Control. 2018;27(5):577.PubMedCrossRef
42.
go back to reference Brown RA, Burgess ES, Sales SD, Whiteley JA, Evans DM, Miller IW. Reliability and validity of a smoking timeline follow-back interview. Psychol Addict Behav. 1998;12(2):101.CrossRef Brown RA, Burgess ES, Sales SD, Whiteley JA, Evans DM, Miller IW. Reliability and validity of a smoking timeline follow-back interview. Psychol Addict Behav. 1998;12(2):101.CrossRef
44.
go back to reference Edelen MO, Tucker JS, Shadel WG, Stucky BD, Cai L. Toward a more systematic assessment of smoking: development of a smoking module for PROMIS®. Addict Behav. 2012;37(11):1278–84.PubMedPubMedCentralCrossRef Edelen MO, Tucker JS, Shadel WG, Stucky BD, Cai L. Toward a more systematic assessment of smoking: development of a smoking module for PROMIS®. Addict Behav. 2012;37(11):1278–84.PubMedPubMedCentralCrossRef
45.
go back to reference Morean M, Krishnan-Sarin S, Sussman S, Foulds J, Fishbein H, Grana R, et al. Psychometric evaluation of the E-cigarette dependence scale. Nicotine Tob Res. 2019;21(11):1556–64.PubMedCrossRef Morean M, Krishnan-Sarin S, Sussman S, Foulds J, Fishbein H, Grana R, et al. Psychometric evaluation of the E-cigarette dependence scale. Nicotine Tob Res. 2019;21(11):1556–64.PubMedCrossRef
46.
go back to reference Etter JF, Sutton S. Assessing ‘stage of change’in current and former smokers. Addiction. 2002;97(9):1171–82.PubMedCrossRef Etter JF, Sutton S. Assessing ‘stage of change’in current and former smokers. Addiction. 2002;97(9):1171–82.PubMedCrossRef
47.
go back to reference Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.PubMedCrossRef Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.PubMedCrossRef
48.
go back to reference Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatric Annals. 2002;32(9):1–7.CrossRef Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatric Annals. 2002;32(9):1–7.CrossRef
49.
go back to reference Stevanovic D. Quality of life enjoyment and satisfaction questionnaire–short form for quality of life assessments in clinical practice: a psychometric study. J Psychiatr Ment Health Nurs. 2011;18(8):744–50.PubMedCrossRef Stevanovic D. Quality of life enjoyment and satisfaction questionnaire–short form for quality of life assessments in clinical practice: a psychometric study. J Psychiatr Ment Health Nurs. 2011;18(8):744–50.PubMedCrossRef
50.
go back to reference Williams MT, Printz D, DeLapp RC. Assessing racial trauma with the trauma symptoms of discrimination scale. Psychol Violence. 2018;8(6):735.CrossRef Williams MT, Printz D, DeLapp RC. Assessing racial trauma with the trauma symptoms of discrimination scale. Psychol Violence. 2018;8(6):735.CrossRef
51.
go back to reference Phinney JS. The multigroup ethnic identity measure: a new scale for use with diverse groups. J Adolesc Res. 1992;7(2):156–76.CrossRef Phinney JS. The multigroup ethnic identity measure: a new scale for use with diverse groups. J Adolesc Res. 1992;7(2):156–76.CrossRef
52.
go back to reference Brown SD, Unger Hu KA, Mevi AA, Hedderson MM, Shan J, Quesenberry CP, et al. The Multigroup ethnic identity Measure—Revised: measurement invariance across racial and ethnic groups. J Couns Psychol. 2014;61(1):154.PubMedCrossRef Brown SD, Unger Hu KA, Mevi AA, Hedderson MM, Shan J, Quesenberry CP, et al. The Multigroup ethnic identity Measure—Revised: measurement invariance across racial and ethnic groups. J Couns Psychol. 2014;61(1):154.PubMedCrossRef
53.
go back to reference Shadel WG, Edelen MO, Tucker JS, Stucky BD, Hansen M, Cai L. Development of the PrOMis® nicotine dependence item banks. Nicotine Tob Res. 2014;16(Suppl 3):190–S201.CrossRef Shadel WG, Edelen MO, Tucker JS, Stucky BD, Hansen M, Cai L. Development of the PrOMis® nicotine dependence item banks. Nicotine Tob Res. 2014;16(Suppl 3):190–S201.CrossRef
54.
go back to reference Piper ME, Piasecki TM, Federman EB, Bolt DM, Smith SS, Fiore MC, et al. A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence motives (WISDM-68). J Consult Clin Psychol. 2004;72(2):139.PubMedCrossRef Piper ME, Piasecki TM, Federman EB, Bolt DM, Smith SS, Fiore MC, et al. A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence motives (WISDM-68). J Consult Clin Psychol. 2004;72(2):139.PubMedCrossRef
55.
go back to reference Smith SS, Piper ME, Bolt DM, Fiore MC, Wetter DW, Cinciripini PM, et al. Development of the brief Wisconsin inventory of smoking dependence motives. Nicotine Tob Res. 2010;12(5):489–99.PubMedPubMedCentralCrossRef Smith SS, Piper ME, Bolt DM, Fiore MC, Wetter DW, Cinciripini PM, et al. Development of the brief Wisconsin inventory of smoking dependence motives. Nicotine Tob Res. 2010;12(5):489–99.PubMedPubMedCentralCrossRef
56.
go back to reference Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K. The Fagerström test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–27.PubMedCrossRef Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K. The Fagerström test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–27.PubMedCrossRef
57.
go back to reference Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict Behav. 2007;32(5):912–23.PubMedCrossRef Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict Behav. 2007;32(5):912–23.PubMedCrossRef
58.
go back to reference Morean ME, Bold KW, The Modified E-cigarette Evaluation questionnaire: psychometric evaluation of an adapted version of the modified cigarette evaluation questionnaire for Use with adults who Use Electronic Nicotine Delivery systems. Nicotine Tob Res. 2022; 24(9), 1396–1404. Morean ME, Bold KW, The Modified E-cigarette Evaluation questionnaire: psychometric evaluation of an adapted version of the modified cigarette evaluation questionnaire for Use with adults who Use Electronic Nicotine Delivery systems. Nicotine Tob Res. 2022; 24(9), 1396–1404.
59.
go back to reference West R, Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology. 2004;177(1–2):195–9.PubMedCrossRef West R, Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology. 2004;177(1–2):195–9.PubMedCrossRef
60.
go back to reference Toll BA, O’Malley SS, McKee SA, Salovey P, Krishnan-Sarin S. Confirmatory factor analysis of the Minnesota nicotine withdrawal scale. Psychol Addict Behav. 2007;21(2):216.PubMedPubMedCentralCrossRef Toll BA, O’Malley SS, McKee SA, Salovey P, Krishnan-Sarin S. Confirmatory factor analysis of the Minnesota nicotine withdrawal scale. Psychol Addict Behav. 2007;21(2):216.PubMedPubMedCentralCrossRef
Metadata
Title
A randomized controlled trial of potential tobacco policies prohibiting menthol flavor in cigarettes and e-cigarettes: a study protocol
Authors
Krysten W. Bold
Akshika Sharma
Angela Haeny
Ralitza Gueorguieva
Eugenia Buta
Stephen Baldassarri
Lauren Lempert
Suchitra Krishnan-Sarin
Stephanie O’Malley
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2024
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-024-05619-0

Other articles of this Issue 1/2024

BMC Psychiatry 1/2024 Go to the issue